Autor: "Sterzing, F." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: SBRT for centrally localized NSCLC - What is too central?
Autorzy:: Roesch J; Department of Radiation Oncology, Universitässpital Zürich, Zürich, Switzerland. .
Panje C; Department of Radiation Oncology, Universitässpital Zürich, Zürich, Switzerland.
Sterzing F; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.
Mantel F; Department of Radiation Oncology, Universitätsklinikum Würzburg, Würzburg, Germany.
Nestle U; Department of Radiation Oncology, Universitätsklinikum Freiburg, Freiburg, Germany.
Andratschke N; Department of Radiation Oncology, Universitässpital Zürich, Zürich, Switzerland.
Guckenberger M; Department of Radiation Oncology, Universitässpital Zürich, Zürich, Switzerland.; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2016 Dec 03; Vol. 11 (1), pp. 157. Date of Electronic Publication: 2016 Dec 03.
Typ publikacji:: Journal Article
MeSH Terms:: Radiosurgery*
Carcinoma, Non-Small-Cell Lung/*pathology
Carcinoma, Non-Small-Cell Lung/*radiotherapy
Lung Neoplasms/*pathology
Lung Neoplasms/*radiotherapy
Humans ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
Autorzy:: Thieke C; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. .; CCU Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. .; Present address: Department of Radiation Oncology, University of Munich (LMU), Marchioninistr. 15, 81377, Munich, Germany. .
Nicolay NH; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.; CCU Molecular Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Sterzing F; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Hoffmann H; Department of Thoracic Surgery, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.
Roeder F; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.; CCU Molecular Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.; Present address: Department of Radiation Oncology, University of Munich (LMU), Marchioninistr. 15, 81377, Munich, Germany.
Safi S; Department of Thoracic Surgery, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.
Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Huber PE; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany. .; CCU Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. .; CCU Molecular Radiation Oncology, German Cancer Research Center, Heidelberg, Germany. .; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2015 Dec 30; Vol. 10, pp. 267. Date of Electronic Publication: 2015 Dec 30.
Typ publikacji:: Journal Article
MeSH Terms:: Chemotherapy, Adjuvant/*methods
Lung Neoplasms/*therapy
Mesothelioma/*therapy
Neoadjuvant Therapy/*methods
Pleural Neoplasms/*therapy
Pneumonectomy/*methods
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/administration & dosage ; Carboplatin/adverse effects ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Combined Modality Therapy ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Female ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Male ; Mesothelioma/mortality ; Mesothelioma, Malignant ; Middle Aged ; Pemetrexed/administration & dosage ; Pemetrexed/adverse effects ; Pleural Neoplasms/mortality ; Proportional Hazards Models ; Radiotherapy Planning, Computer-Assisted ; Radiotherapy, Adjuvant/methods ; Treatment Outcome ; Gemcitabine